Sun Pharma arm Taro Pharma reports Q2 net profit at $8.5 million; revenue rises 13.4%
Taro Pharma's net profit and operating income was adversely impacted by a one-time exceptional expense in Q2.
Stay updated with breaking news from Karo Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Taro Pharma's net profit and operating income was adversely impacted by a one-time exceptional expense in Q2.
/PRNewswire/ -- The "Global Dermatology Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering....
Today, November 17, 2022, MedCap AB (publ) disclosed a public takeover offer to the shareholders of Karo Pharma Aktiebolag. The rules of Nasdaq First North Growth Market state that an issuer may be given observation
/PRNewswire/ -- The Board of Directors of Karo Pharma Aktiebolag ("Karo Pharma" or the "Company") has resolved to apply for de-listing of the Company's shares...
/PRNewswire/ -- Karo Intressenter AB[1] ("Karo Intressenter") announced a public cash offer to the shareholders in Karo Pharma Aktiebolag ("Karo Pharma" or the...